A review of spontaneously reported adverse drug reactions with diclofenac sodium (Voltarol)
- PMID: 161058
A review of spontaneously reported adverse drug reactions with diclofenac sodium (Voltarol)
Abstract
The author reviews the worldwide picture of adverse reactions reported with diclofenac during the four-year period ending in December 1977, at which point he estimates that some ten million patients had received treatment with the drug. A total of 447 unwanted effects were reported in 194 patients, the most frequently reported side-effects being gastrointestinal in nature, followed by dermatological and central nervous system effects. Thirteen cases of liver function abnormality were reported, although there was reason to believe that 11 of these were not ascribable to diclofenac. Twenty haematological effects were reported, including two cases of agranulocytosis and two cases of fatal aplastic anaemia; one patient in each of these groups was taking concomitant pyrazolone compounds. Evaluation of adverse reactions reported with diclofenac suggest a profile in which gastrointestinal side-effects predominate; however, the risk of serious side-effects of this nature is slight, and the impression of good tolerability which emerges from this review is confirmed by the findings of comparative clinical trials.
Similar articles
-
The value and results of long-term studies with diclofenac sodium (Voltarol).Rheumatol Rehabil. 1979;Suppl 2:100-15. Rheumatol Rehabil. 1979. PMID: 394274 Clinical Trial.
-
An open assessment of the efficacy and tolerability of diclofenac sodium (Voltarol) in patients with rheumatic disease and a comparative study of diclofenac sodium (Voltarol) with indomethacin in patients with osteoarthritis and rheumatoid arthritis.Rheumatol Rehabil. 1979;Suppl 2:81-8. Rheumatol Rehabil. 1979. PMID: 394281 Clinical Trial.
-
Diclofenac sodium (Voltarol): a double-blind comparative study with ibuprofen in patients with rheumatoid arthritis.Rheumatol Rehabil. 1979;Suppl 2:89-99. Rheumatol Rehabil. 1979. PMID: 394282 Clinical Trial.
-
[Pharmacodynamics and adverse effects of modern nonsteroid anti-inflammatory agents].Ter Arkh. 1981;53(7):142-51. Ter Arkh. 1981. PMID: 6457407 Review. Russian. No abstract available.
-
[Tissue necrosis: a side effect of sodium diclofenac: report of cases and discussion of the physiopathology].Rev Hosp Clin Fac Med Sao Paulo. 1993 Jan-Feb;48(1):39-42. Rev Hosp Clin Fac Med Sao Paulo. 1993. PMID: 8235269 Review. Portuguese.
Cited by
-
Accidental interaction between PDZ domains and diclofenac revealed by NMR-assisted virtual screening.Molecules. 2013 Aug 9;18(8):9567-81. doi: 10.3390/molecules18089567. Molecules. 2013. PMID: 23966078 Free PMC article.
-
The effect of diclofenac Na (Voltarol) on the haematopoietic cells of bone marrow in sheep.Vet Res Commun. 1998 Sep;22(6):401-3. doi: 10.1023/a:1006149429198. Vet Res Commun. 1998. PMID: 9810636 No abstract available.
-
A case of Stevens-Johnson syndrome, cholestatic hepatitis and haemolytic anaemia associated with use of mefenamic acid.Drug Saf. 1991 May-Jun;6(3):230-4. doi: 10.2165/00002018-199106030-00007. Drug Saf. 1991. PMID: 2064763
-
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.Drugs. 1980 Jul;20(1):24-48. doi: 10.2165/00003495-198020010-00002. Drugs. 1980. PMID: 6772422 Review.
-
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1988 Mar;35(3):244-85. doi: 10.2165/00003495-198835030-00004. Drugs. 1988. PMID: 3286213 Review.